TriSalus Life Sciences (TLSIW) Non-Current Debt (2024 - 2026)

TriSalus Life Sciences (TLSIW) has 3 years of Non-Current Debt data on file, last reported at $33.1 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Debt rose 4.35% year-over-year to $33.1 million; the trailing twelve-month figure through Mar 2026 stood at $33.1 million (up 4.35% YoY), and the FY2025 full-year result was $33.0 million, up 49.64% from the prior year.
• Non-Current Debt for Q1 2026 stood at $33.1 million, roughly flat from $33.0 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $33.1 million in Q1 2026 and bottomed at $21.3 million in Q2 2024.
• The 3-year median for Non-Current Debt is $32.0 million (2025), against an average of $28.5 million.
• The widest annual swing landed in 2025, when Non-Current Debt jumped 51.62%; it then increased 4.35% in 2026.
• A 3-year view of Non-Current Debt shows it stood at $22.1 million in 2024, then jumped by 49.64% to $33.0 million in 2025, then climbed by 0.1% to $33.1 million in 2026.
• The last three Non-Current Debt figures came in at $33.1 million (Q1 2026), $33.0 million (Q4 2025), and $32.8 million (Q3 2025), per Business Quant data.

Peer Comparison